Cybin 2026 Outlook: Clinical Milestones And Cash Position Set Stage For Momentum

CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN ...
PsyPost on MSN

Microdosing psychedelics linked to better sleep and exercise habits

A new study suggests that the practice of taking very small amounts of psychedelics may assist individuals in adopting ...
The Marijuana Herald

Clinical Trial Finds THC and CBD Combination Far More Effective Than Placebo for Treating Acute Migraine

A randomized clinical trial published in the journal Headache finds that a combination of THC and CBD was significantly more effective than placebo for relieving acute migraine pain, offering some of ...
TipRanks on MSN

Almirall advances LAD603 phase 2 alopecia trial, adding optionality to its dermatology pipeline

Almirall SA ($GB:0O9B) announced an update on their ongoing clinical study. Study Overview: Almirall S.A. is running a phase 2 trial called “A ...
CURE

Rusfertide Maintains Hematocrit Control in Patients With Polycythemia Vera

Rusfertide effectively maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 ...

Regeneron Advances Phase 3 Antibody Trial in Birch Pollen Eye Allergy: What Investors Should Know

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Pfizer Completes Early-Stage Acne Trial, Signaling Quiet Expansion in Dermatology

Pfizer Inc (PFE) announced an update on their ongoing clinical study.
Healio

Fenfluramine linked to significantly improved seizure outcomes vs. placebo at 14 weeks

Individuals with a rare form of epilepsy treated with fenfluramine experienced significantly greater seizure reduction as ...